Hunter Associates Investment Management’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $12K | Sell |
|
|||||
|
2024
Q3 | $22K | Hold |
|
|||||
|
2024
Q2 | $22K | Hold |
|
|||||
|
2024
Q1 | $37K | Hold |
|
|||||
|
2023
Q4 | $19K | Sell |
|
|||||
|
2023
Q3 | $20K | Sell |
|
|||||
|
2023
Q2 | $24K | Hold |
|
|||||
|
2023
Q1 | $28K | Sell |
|
|||||
|
2022
Q4 | $38K | Sell |
|
|||||
|
2022
Q3 | $31K | Hold |
|
|||||
|
2022
Q2 | $49K | Buy |
|
|||||
|
2022
Q1 | $41K | Buy |
|
|||||
|
2021
Q4 | $41K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $84K | Buy |
|